CTSI Update
Call for Entrepreneurial Expertise
We seek to identify and help potential entrepreneurs early in the discovery process navigate the pitfalls of commercialization. One of our programs provides direct mentorship to individual researchers. Specifically, we are searching for experienced faculty entrepreneurs to be part of a cadre of experts willing to provide guidance for new entrepreneurs. Learn More
Reminders
Mini Sabbatical Award 2022
Application Deadline: Apr. 12, 2022

The CTSI aims to fund three mini sabbaticals annually at other academic and research institutions, which are intended to encourage intellectual growth and multidisciplinary and inter-institutional collaboration. Foreign travel is not allowed on this award. Learn More
TL1 Predoctoral Fellowships in
Regenerative Medicine
Application Deadline: Apr. 29, 2022

The BU CTSI will support 2 predoctoral fellows as part the CTSI training program in Regenerative Medicine. Students and Faculty interested in this support should submit the following materials. Learn More
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.

The Voucher Program supports the short-term needs of investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for expert consultation services.
Funding Opportunities

Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data.


Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research

National Cancer Institute (NCI)

Single Cell Opioid Responses in the Context of HIV Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)

National Institute on Drug Abuse (NIDA)

Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs


Notice of Special Interest (NOSI) Trial Innovation Center (TIC) Topic Area for Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination

National Center for Advancing Translational Sciences (NCATS)

Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)

National Institute of Allergy and Infectious Diseases (NIAID)

Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)

Fogarty International Center (FIC)

Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed)

National Library of Medicine (NLM)

Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)

National Institute on Minority Health and Health Disparities (NIMHD)
News Highlights

Researchers Race to Understand Long COVID in National Study

To answer the many puzzling questions about long COVID, researchers at Boston University’s School of Medicine and Boston Medical Center (BMC) are beginning to investigate “post-acute sequelae of SARS-CoV-2 (PASC).” Read More

Risk for Blood Clots After COVID-19 Vaccination Explored

There is a small increased risk for intracranial venous thrombosis, thrombocytopenia, and cerebral venous sinus thrombosis (CVST) after the ChAdOx1-S COVID-19 vaccination, but not after the BNT162b2 vaccination. Read More

Omicron Wave Hospitalized 5 Times as Many Young Children as Delta Did


The peak hospitalization rate during Omicron was 14.5 children per 100,000, about five times the peak during Delta, which was 2.9 per 100,000. Read More
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

The sublineage BA.2 of the omicron variant has 16 amino acid substitutions in the receptor-binding domain of the spike (S) protein of SARS-CoV-2,2 which is the primary target for monoclonal antibody–based therapy. Read More
Upcoming Course & Events
e-C3i Program
Applications are due on April 4

The e-C3i course is an online component of the C3i Program and is designed to provide medical device innovators with an educational foundation of business frameworks and tools to assess the opportunity to translate an idea from the lab (concept) to the market (clinic) Read More
Future Directions in Genomics
and Health Equity Research
Apr. 6, 2022, 10 am - 2:15 pm.
Apr. 7, 2022, 11 am - 3 pm.

The goal of the workshop is to identify research gaps and opportunities that will help to decrease health disparities and improve health equity in genomics. Read More
Enabling and Promoting Inter-Institutional Clinical and Genomic Research Un-Meeting
April 13, 2022

The Genomic Information Commons goal is to harmonize IT, regulatory and workflow components across sites for sharing genomic and phenotypic data, as well as biospecimen metadata onconsented cohorts. Read More
The Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.